{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T12:48:52Z","timestamp":1784378932931,"version":"3.55.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Recent successes in the identification of biomarkers and therapeutic targets for diagnosing and managing neurological diseases underscore the critical need for cutting-edge biobanks in the conduct of high-caliber translational neuroscience research. Biobanks dedicated to neurological disorders are particularly timely, given the increasing prevalence of neurological disability among the rising aging population. Translational research focusing on disorders of the central nervous system (CNS) poses distinct challenges due to the limited accessibility of CNS tissue pre-mortem. Nevertheless, technological breakthroughs, including single-cell and single-nucleus methodologies, offer unprecedented insights into CNS pathophysiology using minimal input such as cerebrospinal fluid (CSF) cells and brain biopsies. Moreover, assays designed to detect factors that are released by CNS resident cells and diffuse into the CSF and\/or bloodstream (such as neurofilament light chain [NfL], glial fibrillar acidic protein [GFAP] and amyloid beta peptides), and systemic factors that cross the blood\u2013brain barrier to target CNS-specific molecules (e.g., autoantibodies that bind either the NMDA receptor [NMDAR] or myelin oligodendrocyte glycoprotein [MOG]), are increasingly deployed in clinical research and practice. This review provides an overview of current biobanking practices in neurological disorders and discusses ongoing challenges to biomarker discovery. Additionally, it outlines a rapid consenting and processing pipeline ensuring fresh paired blood and CSF specimens for single-cell sequencing that might more accurately reflect <jats:italic>in vivo<\/jats:italic> pathways. In summary, augmenting biobank rigor and establishing innovative research pipelines using patient samples will undoubtedly accelerate biomarker discovery in neurological disorders.<\/jats:p>","DOI":"10.3389\/fnins.2024.1473917","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T06:38:04Z","timestamp":1735022284000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A mini review of leveraging biobanking in the identification of novel biomarkers in neurological disorders: insights from a rapid single-cell sequencing pipeline"],"prefix":"10.3389","volume":"18","author":[{"given":"Joseph S.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Roell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samruddhi","family":"Ubhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica H.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.nbd.2009.12.029","article-title":"Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis","volume":"38","author":"Achiron","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e2300072","DOI":"10.1002\/prca.202300072","article-title":"Human peripheral blood mononuclear cells as a valuable source of disease-related biomarkers: evidence from comparative proteomics studies","volume":"18","author":"Alexovic","year":"2024","journal-title":"Proteomics Clin. Appl."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fneur.2015.00179","article-title":"A practical guide to immunoassay method validation","volume":"6","author":"Andreasson","year":"2015","journal-title":"Front. Neurol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00428-021-03151-0","article-title":"Basic principles of biobanking: from biological samples to precision medicine for patients","volume":"479","author":"Annaratone","year":"2021","journal-title":"Virchows Arch."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5584\/jiomics.v8i3.236","article-title":"The forensic application of proteomics for the study of the time of death: an operative experimental model for PMI estimation","volume":"8","author":"Aquila","year":"2018","journal-title":"J. Integr. OMICS"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/169203","article-title":"Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly","volume":"2014","author":"Arosio","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"113854","DOI":"10.1016\/j.addr.2021.113854","article-title":"Lack of predictive tools for conventional and targeted cancer therapy: barriers to biomarker development and clinical translation","volume":"176","author":"Batis","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref10","year":""},{"key":"ref12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/neup.12189","article-title":"Arizona study of aging and neurodegenerative disorders and brain and body donation program","volume":"35","author":"Beach","year":"2015","journal-title":"Neuropathology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1161\/STROKEAHA.113.004576","article-title":"Nascent proteomes in peripheral blood mononuclear cells as a novel source for biomarker discovery in human stroke","volume":"45","author":"Bian","year":"2014","journal-title":"Stroke"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaneurol.2019.3238","article-title":"Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis","volume":"77","author":"Bjornevik","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e0178200","DOI":"10.1371\/journal.pone.0178200","article-title":"Autopsy rates in the Netherlands: 35 years of decline","volume":"12","author":"Blokker","year":"2017","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3390\/biology13120957","article-title":"Biobank digitalization: from data acquisition to efficient use","volume":"13","author":"Bukreeva","year":"2024","journal-title":"Biology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4103\/jomfp.jomfp_478_22","article-title":"Evolution of biobanks and ethical governance for the emerging applications in biomedical research","volume":"26","author":"Chandrashekar","year":"2022","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"ref18","first-page":"191","article-title":"OECD guidelines on human biobanks and genetic research databases","volume":"17","year":"2010","journal-title":"Eur. J. Health Law"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/bmm.12.46","article-title":"Recommendations to standardize preanalytical confounding factors in Alzheimer\u2019s and Parkinson\u2019s disease cerebrospinal fluid biomarkers: an update","volume":"6","author":"Del Campo","year":"2012","journal-title":"Biomark. Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement."},{"key":"ref21","year":""},{"key":"ref22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1474-4422(19)30447-8","article-title":"Traumatic brain injury in 2019: databases, biomarkers, and stratified treatment","volume":"19","author":"Feng","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/B978-0-444-63639-3.00004-9","article-title":"The NIH NeuroBioBank: creating opportunities for human brain research","volume":"150","author":"Freund","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","article-title":"Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers","volume":"16","author":"Frisoni","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.tips.2020.09.011","article-title":"CSF and blood biomarkers in neuroinflammatory and neurodegenerative diseases: implications for treatment","volume":"41","author":"Gaetani","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","article-title":"Single-cell genomics unveils critical regulators of Th17 cell pathogenicity","volume":"163","author":"Gaublomme","year":"2015","journal-title":"Cell"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/s41380-023-01976-6","article-title":"The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis","volume":"28","author":"Gigase","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Group","year":"2001","journal-title":"Clin. Pharmacol. Therap."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/gm282","article-title":"Why have protein biomarkers not reached the clinic?","volume":"3","author":"Hanash","year":"2011","journal-title":"Genome Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.ajhg.2021.10.009","article-title":"Genome-wide analysis of common and rare variants via multiple knockoffs at biobank scale, with an application to Alzheimer disease genetics","volume":"108","author":"He","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10561-018-9734-x","article-title":"Separation, banking, and quality control of peripheral blood mononuclear cells from whole blood of melanoma patients","volume":"19","author":"Holland","year":"2018","journal-title":"Cell Tissue Bank."},{"key":"ref33","volume-title":"Best practices for repositories Vancouver, BC, Canada","year":"2018"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"eadf2359","DOI":"10.1126\/science.adf2359","article-title":"Interindividual variation in human cortical cell type abundance and expression","volume":"382","author":"Johansen","year":"2023","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13073-024-01287-7","article-title":"Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis","volume":"16","author":"Kim","year":"2024","journal-title":"Genome Med."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13059-020-1926-6","article-title":"Eleven grand challenges in single-cell data science","volume":"21","author":"Lahnemann","year":"2020","journal-title":"Genome Biol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"fcab086","DOI":"10.1093\/braincomms\/fcab086","article-title":"Biomarkers in neurological disorders: a fast-growing market","volume":"3","author":"Lle\u00f3","year":"2021","journal-title":"Brain Commun."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s42003-023-04713-5","article-title":"Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes","volume":"6","author":"Ma","year":"2023","journal-title":"Commun. Biol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e12916","DOI":"10.1111\/nan.12916","article-title":"microRNA-based predictor for diagnosis of frontotemporal dementia","volume":"49","author":"Magen","year":"2023","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1093\/brain\/awad122","article-title":"Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids","volume":"146","author":"Matsumoto","year":"2023","journal-title":"Brain"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1089\/bio.2017.0108","article-title":"The College of American Pathologists Biorepository Accreditation Program: results from the first 5 years","volume":"16","author":"McCall","year":"2018","journal-title":"Biopreserv. Biobank"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/brainsci11020215","article-title":"Cerebrospinal fluid biomarkers of Alzheimer's disease: current evidence and future perspectives","volume":"11","author":"McGrowder","year":"2021","journal-title":"Brain Sci."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/bio.2020.0159","article-title":"Method optimization of skin biopsy-derived fibroblast culture for reprogramming into induced pluripotent stem cells","volume":"20","author":"Mommaerts","year":"2022","journal-title":"Biopreserv. Biobank"},{"key":"ref46","first-page":"10.3390\/antiox10010028","article-title":"Peripheral blood NRF2 expression as a biomarker in human health and disease","volume":"10","author":"Neilson","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"ref47","first-page":"80","article-title":"Attitudes toward the autopsy--an 8-state survey","volume":"8","author":"Nemetz","year":"2006","journal-title":"MedGenMed"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e12766","DOI":"10.1111\/nan.12766","article-title":"BRAIN UK: accessing NHS tissue archives for neuroscience research","volume":"48","author":"Nicoll","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e20180037","DOI":"10.1542\/peds.2018-0037","article-title":"The biomarker S100B and mild traumatic brain injury: a meta-analysis","volume":"141","author":"Oris","year":"2018","journal-title":"Pediatrics"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/17482968.2011.627589","article-title":"Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS","volume":"13","author":"Otto","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.3390\/ijms23052580","article-title":"Biomarkers in human peripheral blood mononuclear cells: the state of the art in amyotrophic lateral sclerosis","volume":"23","author":"Pansarasa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-1-4939-8935-5_9","article-title":"Procurement, storage, and use of blood in biobanks","volume":"1897","author":"Perry","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.molmed.2012.09.003","article-title":"Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards","volume":"18","author":"Poste","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41467-019-14118-w","article-title":"Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis","volume":"11","author":"Schafflick","year":"2020","journal-title":"Nat. Commun."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"djv012","DOI":"10.1093\/jnci\/djv012","article-title":"Leveraging biospecimen resources for discovery or validation of markers for early cancer detection","volume":"107","author":"Schully","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/bio.2015.0076","article-title":"Sustainability in a hospital-based biobank and university-based DNA biorepository: strategic roadmaps","volume":"13","author":"Seiler","year":"2015","journal-title":"Biopreserv. Biobank"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.2174\/1570159X19666211111123202","article-title":"Changes in John Cunningham virus index in multiple sclerosis patients treated with different disease-modifying therapies","volume":"20","author":"Sgarlata","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1177\/1352458515604381","article-title":"Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis","volume":"22","author":"Signoriello","year":"2016","journal-title":"Mult. Scler."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/joim.12738","article-title":"CCL 23: a new CC chemokine involved in human brain damage","volume":"283","author":"Simats","year":"2018","journal-title":"J. Intern. Med."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0140-6736(03)14541-2","article-title":"Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis","volume":"362","author":"Sorensen","year":"2003","journal-title":"Lancet"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.25291","article-title":"Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein","volume":"84","author":"Spadaro","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref62","volume-title":"ISO 20387: 2018 biotechnology\u2013biobanking\u2013general requirements for biobanking","year":"2018"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jalz.2019.08.189","article-title":"Prediction of Alzheimer's disease diagnosis within 14 years through Abeta misfolding in blood plasma compared to APOE4 status, and other risk factors","volume":"16","author":"Stocker","year":"2020","journal-title":"Alzheimers Dement."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/jnci\/djp334","article-title":"A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment","volume":"101","author":"Taube","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-018-0359-x","article-title":"White paper by the society for CSF analysis and clinical neurochemistry: overcoming barriers in biomarker development and clinical translation","volume":"10","author":"Teunissen","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clinbiochem.2013.12.024","article-title":"Biobanking of CSF: international standardization to optimize biomarker development","volume":"47","author":"Teunissen","year":"2014","journal-title":"Clin. Biochem."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"eabb1654","DOI":"10.1126\/sciadv.abb1654","article-title":"Noninvasive characterization of Alzheimer's disease by circulating, cell-free messenger RNA next-generation sequencing","volume":"6","author":"Toden","year":"2020","journal-title":"Sci. Adv."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/1352458512460604","article-title":"Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis","volume":"19","author":"Vennegoor","year":"2013","journal-title":"Mult. Scler."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"8196","DOI":"10.1038\/s41598-022-12178-5","article-title":"Delayed processing of blood samples impairs the accuracy of mRNA-based biomarkers","volume":"12","author":"Wilson","year":"2022","journal-title":"Sci. Rep."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1146\/annurev-genom-091212-153506","article-title":"Return of individual research results and incidental findings: facing the challenges of translational science","volume":"14","author":"Wolf","year":"2013","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/s12276-021-00714-8","article-title":"Single-cell RNA sequencing reveals B cell-related molecular biomarkers for Alzheimer's disease","volume":"53","author":"Xiong","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"645666","DOI":"10.3389\/fimmu.2021.645666","article-title":"Single-cell RNA sequencing of peripheral blood reveals immune cell signatures in Alzheimer's disease","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Immunol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.saa.2016.10.041","article-title":"Characterization of postmortem biochemical changes in rabbit plasma using ATR-FTIR combined with chemometrics: a preliminary study","volume":"173","author":"Zhang","year":"2017","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/jpm10030085","article-title":"Current biomarkers for Alzheimer's disease: from CSF to blood","volume":"10","author":"Zou","year":"2020","journal-title":"J. Pers. Med."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1473917\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T06:38:08Z","timestamp":1735022288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1473917\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":75,"alternative-id":["10.3389\/fnins.2024.1473917"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2024.1473917","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"article-number":"1473917"}}